CLINICAL_TRIALS
research
· 2025-12-23
Clinical Trial Update: MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer: The IMAGINg and Epidemiology (IMAGINE) Study
Summary
The IMAGINE study is exploring whether MRI background parenchymal enhancement is a risk factor for breast cancer, and the trial is currently active but not recr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | Status: ACTIVE_NOT_RECRUITING